We use cookies to measure traffic and show relevant ads. By clicking Accept you agree to our use of analytics and advertising cookies.
mRNA vaccine Moderna against influenza outperformed traditional vaccines in a trial with 40,000 participants. Learn how this will change the market and when to expect the FDA decision.
